Literature DB >> 20378669

Escherichia coli ST131 producing CTX-M-15 in Australia.

Hanna E Sidjabat, Petra Derrington, Graeme R Nimmo, David L Paterson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20378669     DOI: 10.1093/jac/dkq098

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  16 in total

Review 1.  Host-pathogen checkpoints and population bottlenecks in persistent and intracellular uropathogenic Escherichia coli bladder infection.

Authors:  Thomas J Hannan; Makrina Totsika; Kylie J Mansfield; Kate H Moore; Mark A Schembri; Scott J Hultgren
Journal:  FEMS Microbiol Rev       Date:  2012-05       Impact factor: 16.408

2.  Deciphering the roles of outer membrane protein A extracellular loops in the pathogenesis of Escherichia coli K1 meningitis.

Authors:  Rahul Mittal; Subramanian Krishnan; Ignacio Gonzalez-Gomez; Nemani V Prasadarao
Journal:  J Biol Chem       Date:  2010-11-11       Impact factor: 5.157

Review 3.  Escherichia coli ST131, an intriguing clonal group.

Authors:  Marie-Hélène Nicolas-Chanoine; Xavier Bertrand; Jean-Yves Madec
Journal:  Clin Microbiol Rev       Date:  2014-07       Impact factor: 26.132

4.  Evaluation of a new chromogenic medium, chromID OXA-48, for recovery of carbapenemase-producing Enterobacteriaceae from patients at a university hospital in Turkey.

Authors:  P Zarakolu; K M Day; H E Sidjabat; W Kamolvit; C V Lanyon; S P Cummings; D L Paterson; M Akova; J D Perry
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-10-12       Impact factor: 3.267

5.  Molecular characterization of Escherichia coli strains that cause symptomatic and asymptomatic urinary tract infections.

Authors:  Sam Abraham; Toni A Chapman; Ren Zhang; James Chin; Amanda N Mabbett; Makrina Totsika; Mark A Schembri
Journal:  J Clin Microbiol       Date:  2011-12-21       Impact factor: 5.948

6.  Commonality among fluoroquinolone-resistant sequence type ST131 extraintestinal Escherichia coli isolates from humans and companion animals in Australia.

Authors:  Joanne L Platell; Rowland N Cobbold; James R Johnson; Anke Heisig; Peter Heisig; Connie Clabots; Michael A Kuskowski; Darren J Trott
Journal:  Antimicrob Agents Chemother       Date:  2011-06-06       Impact factor: 5.191

7.  Exploring the inhibition of CTX-M-9 by beta-lactamase inhibitors and carbapenems.

Authors:  Christopher R Bethel; Magdalena Taracila; Teresa Shyr; Jodi M Thomson; Anne M Distler; Kristine M Hujer; Andrea M Hujer; Andrea Endimiani; Krisztina Papp-Wallace; Richard Bonnet; Robert A Bonomo
Journal:  Antimicrob Agents Chemother       Date:  2011-05-09       Impact factor: 5.191

8.  Prominence of an O75 clonal group (clonal complex 14) among non-ST131 fluoroquinolone-resistant Escherichia coli causing extraintestinal infections in humans and dogs in Australia.

Authors:  Joanne L Platell; Darren J Trott; James R Johnson; Peter Heisig; Anke Heisig; Connie R Clabots; Brian Johnston; Rowland N Cobbold
Journal:  Antimicrob Agents Chemother       Date:  2012-04-23       Impact factor: 5.191

9.  Dominance of IMP-4-producing enterobacter cloacae among carbapenemase-producing Enterobacteriaceae in Australia.

Authors:  Hanna E Sidjabat; Nicola Townell; Graeme R Nimmo; Narelle M George; Jennifer Robson; Renu Vohra; Louise Davis; Claire Heney; David L Paterson
Journal:  Antimicrob Agents Chemother       Date:  2015-04-27       Impact factor: 5.191

10.  Interspecies transfer of blaIMP-4 in a patient with prolonged colonization by IMP-4-producing Enterobacteriaceae.

Authors:  Hanna E Sidjabat; Claire Heney; Narelle M George; Graeme R Nimmo; David L Paterson
Journal:  J Clin Microbiol       Date:  2014-07-23       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.